705MO Sitravatinib (sitra) in combination with nivolumab...

Annals of Oncology 2020 / 09 Vol. 31

705MO Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naïve, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC)

Msaouel, P., Siefker-Radtke, A.O., Sweis, R., Mao, S., Rosenberg, J.E., Vaishampayan, U.N., Kalebasty, A. Rezazadeh, Pili, R., Bupathi, M., Nordquist, L.T., Shaffer, D.R., Davis, N., Zhang, T., Gandhi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.777
Date:
September, 2020
File:
PDF, 74 KB
2020
Conversion to is in progress
Conversion to is failed